Investors

Introduction

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company primarily focused on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system (LUNAR™) and UNA Oligomer chemistry technologies.

The Investor Relations section is designed to provide easy access to company information.

NASDAQ: ARCT

$ 9.37

4:00 PM | Jan 22, 2018
$0.00
(0.00%)

Day High: N/A
Day Low:  N/A
Volume:    N/A
Delayed ~20 min., by eSignal.